AMD to Participate in Upcoming Investor Conferences

AMD (NASDAQ: AMD) announced today that company executives will participate in the following events for the financial community:

  • Dr. Lisa Su, chair and chief executive officer, will present at UBS's 2025 Global Technology and AI Conference on Wednesday, Dec. 3, 2025.
  • Jean Hu, executive vice president, chief financial officer and treasurer, will present at Barclay's 2025 Global Technology Conference on Wednesday, Dec. 10, 2025.

Interested parties are invited to listen to the live webcasts and replays via the AMD Investor Relations website ir.amd.com .

About AMD
For more than 55 years AMD has driven innovation in high-performance computing, graphics and visualization technologies. Billions of people, leading Fortune 500 businesses and cutting-edge scientific research institutions around the world rely on AMD technology daily to improve how they live, work and play. AMD employees are focused on building leadership high-performance and adaptive products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website , blog , LinkedIn , Facebook and X pages.

AMD, the AMD Arrow logo and the combination thereof are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

Contact
Phil Hughes
AMD Communications
512-865-9697
phil.hughes@amd.com

Liz Stine
AMD Investor Relations
(720) 652-3965
liz.stine@amd.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

AMD
The Conversation (0)
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical drug development company focused on developing a pipeline of proprietary small-molecule drug candidates for diseases with high unmet medical needs, today reports financial results for its first quarter of... Keep Reading...
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of Mr. John Bathery to its Board of Directors,... Keep Reading...
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer's disease pathology Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration Cash of $11.1M to support pharmaceutical developments into the fourth... Keep Reading...
InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today reports financial results for the second quarter of the fiscal year 2025... Keep Reading...
InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a significant safety marginDose ranging studies completed InMed Pharmaceuticals Inc. (NASDAQ:... Keep Reading...
Closeup of banknote with overlaid stock market data and charts.

Tech Weekly: Tech Stocks Feel the Heat Amid Valuation Fears

Welcome to the Investing News Network's weekly brief on tech news and tech stocks driving the markets. We also break down next week's catalysts to watch to help you prepare for the week ahead.Don't forget to follow us @INN_Technology for real-time news updates!Securities Disclosure: I, Meagen... Keep Reading...
Westport Reveals CNG Solution for Natural Gas HPDI Engines and North America's Clean Transportation Future

Westport Reveals CNG Solution for Natural Gas HPDI Engines and North America's Clean Transportation Future

Westport Fuel Systems Inc. ("Westport") (TSX:WPRT Nasdaq: WPRT), a supplier of alternative fuel systems and components for the global transportation industry, today announces a breakthrough solution designed to dramatically expand the addressable market for HPDI™ while significantly improving... Keep Reading...
September 2025 Quarterly Activities & Appendix 4C Cashflow

September 2025 Quarterly Activities & Appendix 4C Cashflow

Provaris Energy (PV1:AU) has announced September 2025 Quarterly Activities & Appendix 4C CashflowDownload the PDF here. Keep Reading...
Appendix 4C and Cover Ltr qtr ending 30 Sep 2025

Appendix 4C and Cover Ltr qtr ending 30 Sep 2025

Energy Technologies (EGY:AU) has announced Appendix 4C and Cover Ltr qtr ending 30 Sep 2025Download the PDF here. Keep Reading...
Homerun Resources Inc. Rare Earth Element  Separation Technology Partnership

Homerun Resources Inc. Rare Earth Element Separation Technology Partnership

Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) ("Homerun" or the "Company") is pleased to announce that it has executed a binding Memorandum of Understanding ("MoU") with Magnum Mining & Exploration Limited ("Magnum") (ASX: MGU) (OTCQB: MGUFF), to jointly evaluate the application of... Keep Reading...
Q1 FY26 Quarterly Activities Report & Appendix 4C

Q1 FY26 Quarterly Activities Report & Appendix 4C

Carbonxt Group (CG1:AU) has announced Q1 FY26 Quarterly Activities Report & Appendix 4CDownload the PDF here. Keep Reading...

Latest Press Releases

Related News